Zai Lab (NasdaqGM:ZLAB) FY Conference January 13, 2026 06:00 PM ET Company ParticipantsJosh Smiley - COORafael Amado - Head of R&DConference Call ParticipantsNone - Analyst 2None - Analyst 1None - Analyst 3Anupam Rama - Senior Biotech AnalystAnupam RamaAll right, let's go ahead and get started. Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name's Anupam Rama. I am one of the Senior Biotech Analysts here at JPMorgan. I'm joined by my squad: Rafi Pinheiro, Joyce Zhao, and Priyanka G ...

R&D Strategy Overview - The company is focusing on both organic and inorganic growth in its R&D strategy, particularly in the science of the immune system and the application of technologies [1][2] - Over the past three years, the company has aimed to create a research unit focused R&D organization [2] Internal and External Components - The business development (BD) team, led by Chris Sheldon, reports directly to the Chief Scientific Officer, indicating a strategic design to integrate both external and internal opportunities in portfolio decision-making [3] - The focus has been on transitioning into marketed assets, which has driven the company's recent activities [3]